Abstract

The COVID-19 pandemic has revealed that viruses can have multiple receptor properties, penetrating various tissues and causing mutations in various genes, thus promoting a range of metabolic disorders. The purpose of this study was to investigate the connection between three factors: diabetic status, pre-hospitalization oxygen therapy, and saturation levels, to the values of morphological, inflammatory, and biochemical parameters in the blood serum of COVID-19 patients. The study group consisted of 2139 patients, 1076 women (50.30%) and 1063 men (49.70%), with an average age of 63.73 ± 15.69 years. The population was divided into three groups based on a three-stage scale, taking into account patients with either type 2 diabetes/prediabetes (473 patients), those who received oxygen therapy before hospitalization, and those with a saturation value of below 95% (cut-off value). Among patients who did not receive pre-hospitalization oxygen therapy, those with diabetes and a SpO2 level < 95% had significantly higher levels of D-dimers, procalcitonin, albumin, lymphocytes, RDW-SD ≥ 47, potassium, creatinine, and troponin T when compared to diabetic patients with a SpO2 level ≥ 95%. Similarly, in the same group of patients without pre-hospitalization oxygen therapy, those without diabetes but with a SpO2 level < 95% showed significantly increased levels of IL-6, CRP, albumin, lymphocytes, RDW-SD ≥ 47, glucose, potassium, sodium, creatinine, and ALT, compared to patients without diabetes and with a SpO2 level ≥ 95%. The findings suggest that lower saturation levels may result in increased potassium and glucose levels in patients who did not receive any oxygen therapy before hospitalization due to COVID-19. It is hypothesized that this may be caused by damage to pancreatic β-cells by SARS-CoV-2, and disturbances in the potassium channel, leading to cell membrane depolarization and insulin secretion.

Details

Title
Pre-hospital oxygen therapy and saturation variability in COVID-19 patients with and without glucose metabolism disorders: part of the COLOS Study
Author
Bronowicka-Szydełko, Agnieszka 1 ; Lewandowski, Łukasz 1 ; Lubieniecki, Pawel 2 ; Adamiec-Mroczek, Joanna 3 ; Doroszko, Adrian 4 ; Trocha, Małgorzata 2 ; Kujawa, Krzysztof 5 ; Matera-Witkiewicz, Agnieszka 6 ; Rabczyński, Maciej 2 ; Kuźnik, Edwin 2 ; Madziarski, Marcin 7 ; Sokołowski, Janusz 8 ; Jankowska, Ewa A. 9 ; Madziarska, Katarzyna 2 

 Wroclaw Medical University, Department of Biochemistry and Immunochemistry, Wrocław, Poland (GRID:grid.4495.c) (ISNI:0000 0001 1090 049X) 
 Wroclaw Medical University, Clinical Department of Diabetology and Internal Disease, Faculty of Medicine, Wroclaw, Poland (GRID:grid.4495.c) (ISNI:0000 0001 1090 049X) 
 Wroclaw Medical University, Clinical Department of Ophthalmology, Wroclaw, Poland (GRID:grid.4495.c) (ISNI:0000 0001 1090 049X) 
 Wroclaw Medical University, Clinical Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw, Poland (GRID:grid.4495.c) (ISNI:0000 0001 1090 049X) 
 Wroclaw Medical University, Statistical Analysis Centre, Wroclaw, Poland (GRID:grid.4495.c) (ISNI:0000 0001 1090 049X) 
 Wroclaw Medical University Biobank, Wroclaw Medical University, Screening of Biological Activity Assays and Collection of Biological Material Laboratory, Faculty of Pharmacy, Wroclaw, Poland (GRID:grid.4495.c) (ISNI:0000 0001 1090 049X) 
 Wroclaw Medical University, Clinical Department of Rheumatology and Internal Medicine, Wroclaw, Poland (GRID:grid.4495.c) (ISNI:0000 0001 1090 049X) 
 Wroclaw Medical University, Department of Emergency Medicine, Wroclaw, Poland (GRID:grid.4495.c) (ISNI:0000 0001 1090 049X) 
 Wroclaw Medical University, Institute of Heart Diseases, Wroclaw, Poland (GRID:grid.4495.c) (ISNI:0000 0001 1090 049X) 
Pages
19286
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3094940972
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.